Your AI-Trained Oncology Knowledge Connection!

Optimizing Therapy for Patients Radioactive Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC) : Episode 1

Opinion

Video

March 22, 2024

Differentiated Thyroid Cancer: Examining Key Epidemiological Trends

Medical experts provide an overview of differentiated thyroid cancer, highlighting key epidemiological trends, and discuss the impact of thyroid cancer in women.

Now Viewing

EP: 1.Differentiated Thyroid Cancer: Examining Key Epidemiological Trends

EP: 2.Exploring Incidence and Histology of Differentiated Thyroid Cancer

EP: 3.Determining Prognosis for Patients with Differentiated Thyroid Cancer

EP: 4.Predisposition for Patients Developing DTC: Age and Gender

EP: 5.The Role of Molecular Diagnostics in Real-World DTC Management

EP: 6.Employing Liquid Biopsies and ctDNA in DTC Diagnostic Strategies

EP: 7.The Importance of Thyroidectomy in DTC Patient Care

EP: 8.Post-Thyroidectomy Management: Thyroid Hormone Replacement and TSH Suppression

EP: 9.Identifying RAI-Refractory Disease: A Key Aspect of DTC Management

EP: 10.SELECT Trial & DECISION Trial Outcomes and Lessons Learned

EP: 11.Determining Which DTC Patients May Benefit from Systemic Therapy

EP: 12.Exploring Real-World Evidence Presented at ATA 2023

EP: 13.Understanding the Impact of COSMIC-311 and Sequencing in DTC

EP: 14.Toxicity Profiles for DTC Guidelines Therapies

EP: 15.Addressing Unmet Needs and Challenges in RAI-R-DTC Treatment

EP: 16.Neoadjuvant Approach in RAI-R-DTC

EP: 17.Phase 2 ATLEP Trial Results

EP: 18.Reflecting on Differentiated Thyroid Cancer: Final Insights

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All

Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity

Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity

Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity

Latest Conference Coverage

Hematologists Highlight Notable Insights From the 2025 EHA Congress

Post Hoc Analysis Shows Imetelstat Drives Benefit in RS-Negative, Lower-Risk MDS

Bexobrutideg Is Tolerable and Yields High Response Rates in Relapsed/Refractory Waldenström Macroglobulinemia

Axi-Cel, Liso-Cel, and Tisa-Cel Show Comparable Real-World Survival Outcomes in DLBCL

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

Differentiated Thyroid Cancer: Examining Key Epidemiological Trends

EP: 1.Differentiated Thyroid Cancer: Examining Key Epidemiological Trends

EP: 2.Exploring Incidence and Histology of Differentiated Thyroid Cancer

EP: 3.Determining Prognosis for Patients with Differentiated Thyroid Cancer

EP: 4.Predisposition for Patients Developing DTC: Age and Gender

EP: 5.The Role of Molecular Diagnostics in Real-World DTC Management

EP: 6.Employing Liquid Biopsies and ctDNA in DTC Diagnostic Strategies

EP: 7.The Importance of Thyroidectomy in DTC Patient Care

EP: 8.Post-Thyroidectomy Management: Thyroid Hormone Replacement and TSH Suppression

EP: 9.Identifying RAI-Refractory Disease: A Key Aspect of DTC Management

EP: 10.SELECT Trial & DECISION Trial Outcomes and Lessons Learned

EP: 11.Determining Which DTC Patients May Benefit from Systemic Therapy

EP: 12.Exploring Real-World Evidence Presented at ATA 2023

EP: 13.Understanding the Impact of COSMIC-311 and Sequencing in DTC

EP: 14.Toxicity Profiles for DTC Guidelines Therapies

EP: 15.Addressing Unmet Needs and Challenges in RAI-R-DTC Treatment

EP: 16.Neoadjuvant Approach in RAI-R-DTC

EP: 17.Phase 2 ATLEP Trial Results

EP: 18.Reflecting on Differentiated Thyroid Cancer: Final Insights

Newsletter

Latest CME

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer

Latest Conference Coverage